“Peripheral-Blood Stem Cells Versus Bone Marrow From Unrelated Donors”. N Engl J Med 367. N Engl J Med: 1487-1496. http://www.ncbi.nlm.nih.gov/pubmed/23075175.
. 2012. “Autologous Vs. Reduced Intensity Allogeneic Hematopoietic Cell Transplantation For Patients With Chemosensitive Follicular Non-Hodgkin's Lymphoma Beyond First Complete Response Or First Partial Response”. Biol Blood Marrow Transplant 17. Biol Blood Marrow Transplant: 1051-1057. http://www.ncbi.nlm.nih.gov/pubmed/21073974.
. 2011. “Autologous Vs. Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation For Patients With Follicular Non-Hodgkins Lymphoma (Fl) Beyond First Complete Response Or First Partial Response”. In American Society Of Clinical Oncology Annual Meeting. American Society Of Clinical Oncology Annual Meeting. Chicago, IL. http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst_meeting_categories_view&confID=55.
. 2008. “Use Of Biological Assignment In Hematopoietic Stem Cell Transplantation Clinical Trials”. Clin Trials 5. Clin Trials: 607-616. http://www.ncbi.nlm.nih.gov/pubmed/19029209.
. 2008.